Courses

This CE activity will highlight novel therapies to slow disease progression in patients with early-stage Alzheimer’s disease (AD), including data presented at the Virtual 13^th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Digital Conference 2020. The expert faculty, led by Dr. Richard S. Isaacson, will first delve into the pathophysiology, early and accurate differential diagnosis and disease course of Alzheimer’s ...
View Course

In this module, Perry Shieh, MD, PhD, along with Claudia Chiriboga, MD, MPH, course chair, will review strategies for the long-term treatment of SMA to optimize patient outcomes. The expert faculty will discuss long-term efficacy and safety data in order to develop effective SMA patient management strategies with the interprofessional team and identify available resources for optimal care while the ...
View Course

In this module, Julie Parsons, MD, along with Claudia Chiriboga, MD, MPH, course chair, will review the benefits and long-term effects of presymptomatic treatment for patients with spinal muscular atrophy (SMA). The faculty will discuss the benefits of early disease diagnosis and how to implement presymptomatic treatment in infants with SMA. Upon completion of this 30-minute module, clinicians will gain ...
View Course

In this module, Basil Darras, MD, along with Claudia Chiriboga, MD, MPH, course chair, will analyze current and emerging therapeutic options for patients with spinal muscular atrophy (SMA). The faculty will review recent data of both available and investigational therapeutic options for the treatment of patients with SMA. Upon completion of this 30-minute module, learners will gain insight into current ...
View Course

In this module, Wendy Chung, MD, PhD, along with Claudia Chiriboga, MD, MPH, course chair, will review the applications of genetic screening for patients with spinal musical atrophy (SMA). The faculty will discuss updates in screening techniques, as well as advances in genetic testing for infants with SMA. Upon completion of this 30-minute module, clinicians will be better equipped with ...
View Course

In this module, John Brandsema MD, along with Claudia Chiriboga, MD, MPH, course chair, will review information released at the Virtual CureSMA Conference 2020. Dr. Brandsema will provide an in-depth overview of recent clinical trial data of current and emerging therapeutics for SMA, and the expert faculty will dive into a discussion on the details of these clinical trials and ...
View Course

In this module, Oscar Henry Mayer, MD, along with Claudia Chiriboga, MD, MPH, course chair, will discuss strategies for managing spinal muscular atrophy (SMA) patients during the COVID-19 pandemic. Current clinical recommendations from CureSMA for the management of patients with SMA will be reviewed during the interview segment. Best practices for avoiding care disruption for SMA patients during the COVID-19 ...
View Course

This six-episode podcast interview series, chaired by Dr. Fred Lublin, highlights recent advances in the treatment and management of patients with multiple sclerosis (MS), including clinical considerations amidst the COVID-19 pandemic. In this series, the expert faculty will analyze recent clinical trial data, including that presented at Joint ACTRIMS-ECTRIMS MS Virtual 2020. Advances in diagnostic tools, biomarkers and imaging in ...
View Course

This six-episode podcast interview series is chaired by Dr. Richard Isaacson and includes information from the AAIC 2020 Virtual Conference. Dr. Isaacson interviews five expert faculty on the six agenda topics that will include how to best manage Alzheimer’s patients during the COVID-19 Pandemic and transitioning to telemedicine. The discussions will also cover clinical trial data, early diagnosis, imaging, and ...
View Course

This CME program is enduring material from a symposium given by Dr. Teshamae Monteith at the Florida Society of Neurology 2020 Virtual Meeting hosted on October 3, 2020 regarding difficult-to-treat migraine. Dr. Monteith covers the diagnosis of migraine and the impact this can have on the patient as well as social determinants and risk factors for migraine. Recent clinical trials ...
View Course